太阳集团tyc5997_平台(china)官方网站

表皮生长因子受体(EGFR)单克隆抗体

Monoclonal Antibody to Epidermal Growth Factor Receptor (EGFR)

ErbB-1; ErbB1; ER1; ERB-B1; MENA; HER1; Erythroblastic Leukemia Viral(v-Erb-B)oncogene Homolog,Avian; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1

  • 表皮生长因子受体(EGFR)单克隆抗体 产品包装(模拟)
  • 表皮生长因子受体(EGFR)单克隆抗体 产品包装(模拟)
  • 表皮生长因子受体(EGFR)单克隆抗体 DAB staining on IHC-P; Sample: Human Placenta Tissue; Primary Ab: 10µg/ml Mouse Anti-Human EGFR Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • 表皮生长因子受体(EGFR)单克隆抗体 FITC staining on IF;
    Sample: Human Hela cell;
    Primary Ab: 20µg/ml Mouse Anti-Human EGFR Antibody
    Second Ab: 5µg/ml FITC-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu18)
  • 表皮生长因子受体(EGFR)单克隆抗体 AF488 staining on IF;
    Sample: Hela cell
    Primary Ab: 20µg/ml Mouse Anti-Human EGFR Antibody
    Second Ab: 2μg/ml AF488-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu11)
  • MAA757Hu24.jpg Western Blot; Sample: Porcine Cerebrum lysate Primary Ab: 0.01µg/ml Mouse Anti-Human EGFR Antibody Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • 表皮生长因子受体(EGFR)单克隆抗体 Western Blot; Sample: Lane1: Hela cell lysate; Lane2: MCF7 cell lysate; Lane3: A431 cell lysate; Lane4: Human Placenta lysate
    Primary Ab: 0.01µg/ml Mouse Anti-Human EGFR Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu19)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对EGFR的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别EGFR。

用法

Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号 适用物种：Homo sapiens (Human，人) 应用(仅供研究使用，不用于临床诊断！)
APA757Hu62 表皮生长因子受体(EGFR)活性蛋白 Cell culture; Activity Assays.
RPA757Hu01 表皮生长因子受体(EGFR)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA757Hu61 表皮生长因子受体(EGFR)活性蛋白 Cell culture; Activity Assays.
EPA757Hu62 表皮生长因子受体(EGFR)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA757Hu02 表皮生长因子受体(EGFR)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
EPA757Hu61 表皮生长因子受体(EGFR)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA757Hu06 表皮生长因子受体(EGFR)多克隆抗体 WB; IHC; ICC; IP.
PAA757Hu02 表皮生长因子受体(EGFR)多克隆抗体 WB; IHC; ICC; IP.
PAA757Hu01 表皮生长因子受体(EGFR)多克隆抗体 WB; IHC; ICC; IP.
FAA757Hu51 抗表皮生长因子受体(EGFR)多克隆抗体(别藻蓝蛋白标记) FCM
MAA757Hu27 表皮生长因子受体(EGFR)单克隆抗体 WB; IHC; ICC; IP.
MAA757Hu29 表皮生长因子受体(EGFR)单克隆抗体 WB; IHC; ICC; IP.
RAA757Hu21 表皮生长因子受体(EGFR)重组抗体 WB; IF; ICC; IHC; IP; FCM.
MAA757Hu21 表皮生长因子受体(EGFR)单克隆抗体 WB; IHC; ICC; IP.
MAA757Hu23 表皮生长因子受体(EGFR)单克隆抗体 WB; IHC; ICC; IP.
MAA757Hu24 表皮生长因子受体(EGFR)单克隆抗体 WB; IHC; ICC; IP.
MAA757Hu25 表皮生长因子受体(EGFR)单克隆抗体 WB; IHC; ICC; IP.
MAA757Hu22 表皮生长因子受体(EGFR)单克隆抗体 WB; IHC
SEA757Hu 表皮生长因子受体(EGFR)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
HEA757Hu 表皮生长因子受体(EGFR)检测试剂盒(酶联免疫吸附试验法,高敏型) Enzyme-linked immunosorbent assay for Antigen Detection.
AEA757Hu 抗表皮生长因子受体抗体(Anti-EGFR)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antibody Detection.
LMA757Hu 表皮生长因子受体(EGFR)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.

参考文献

杂志 参考文献
Thoracic Cancer Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer [Wiley: source]
J Cent Nerv Syst Dis.? Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism … [Pubmed:25249767]
Mol Cancer Ther GC1118, an anti-EGFR antibody with a distinct binding epitope and superior inhibitory activity against high-affinity EGFR ligands [PubMed: 26586721]
Cell Death Dis.  LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway [Pubmed:26938303]
analytica chimica acta Microfluidic immunosensor based on mesoporous silica platform and CMK-3/poly-acrylamide-co-methacrylate of dihydrolipoic acid modified gold electrode for cancer biomarker detection. [pubmed:28335979]
Talanta EGFR detection in extracellular vesicles of breast cancer patients through immunosensor based on silica-chitosan nanoplatform [Doi: 10.1016/j.talanta.2018.10.016]
Bioorganic Chemistry Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers [Pubmed: 30665034]
Journal of enzyme inhibition and medicinal chemistry Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile [Pubmed: 30919701]
Bioorganic Chemistry Design and synthesis of new benzoxazole/benzothiazole-phthalimide hybrids as antitumor-apoptotic agents []
Bioorganic Chemistry Synthesis and anticancer activity of bis-benzo [d][1, 3] dioxol-5-yl thiourea derivatives with molecular docking study [Pubmed: 31288134]
Oxidative Medicine and Cellular Longevity Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters … [Pubmed: 31737175]
Neoplasia Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine [Pubmed: 33212364]
Association between Serum Epidermal Growth Factor Receptor and Cyclooxygenase-2 Levels in Patients with Non-small Cell Carcinoma of Lung []
Synthesis, EGFR-TK inhibition and anticancer activity of new quinoxaline derivatives []
IMMUNOLOGIC RESEARCH Humoral immune response to epidermal growth factor receptor in lung cancer [33495907]
European Journal of Medicinal Chemistry Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure¨Cactivity relationship and biological activity as potential antitumor and anticonvulsant agents [33545637]
Journal of Molecular Structure Design, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors []
ACS Appl Mater Interfaces Emitter–Quencher Pair of Single Atomic Co Sites and Monolayer Titanium Carbide MXenes for Luminol Chemiluminescent Reactions [34914377]
Bioorganic Chemistry Discovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies [Pubmed:35219045]
留言咨询
Baidu
sogou